Rozanolixizumab for treating antibody-positive generalised myasthenia gravis

  • Technology appraisal guidance
  • TA1155
  • Published: 

History

Documents created during the development process.

Final draft guidance

Declaration of interests

Draft guidance: 1

Declaration of interests

Committee meetings

  • Committee meeting

  • Committee meeting: 2

  • Committee meeting: 3

Invitation to participate

Notes

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 5092

Topic selection